surpass cvot tirzepatide results Efficacy and safety of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial SURPASS-CVOT trial results: Tirzepatide's impact

try ginger tea

Research found that AG reduced insulin secretion in humans or isolated islets, and a large dose of AG caused IR [82, 90,91,92]

The difference between elevated or unchanged GLP-1 levels in obese patients may be related to differences in metabolic status and detection methods, but the significant correlation between GLP-1 and lipid metabolism suggests that it can control weight and regulate lipid metabolism in HF diet groups, and GLP-1 has the potential to treat obesity caused by HF diet [102]

In fact, Ozempic became so popular for weight loss, that it was being hoarded for this purpose, creating a shortage for actual diabetics who needed it

GLP-1 (glucagon-like peptide-1) medications were originally developed to treat Type 2 diabetes, but researchers discovered something remarkable: people were also losing significant amounts of weight

503A individual patient compounding continued